Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $32000.0.

  • Assembly Biosciences' Depreciation & Amortization (CF) fell 303.03% to $32000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $129000.0, marking a year-over-year decrease of 2872.93%. This contributed to the annual value of $129000.0 for FY2024, which is 7133.33% down from last year.
  • Per Assembly Biosciences' latest filing, its Depreciation & Amortization (CF) stood at $32000.0 for Q3 2025, which was down 303.03% from $32000.0 recorded in Q2 2025.
  • Assembly Biosciences' 5-year Depreciation & Amortization (CF) high stood at $134000.0 for Q3 2022, and its period low was $32000.0 during Q1 2024.
  • Its 5-year average for Depreciation & Amortization (CF) is $86315.8, with a median of $116000.0 in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 1260.5% in 2022, then crashed by 7460.32% in 2024.
  • Assembly Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $120000.0 in 2021, then rose by 3.33% to $124000.0 in 2022, then tumbled by 32.26% to $84000.0 in 2023, then crashed by 61.9% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $32000.0 in Q3 2025, compared to $32000.0 in Q2 2025 and $33000.0 in Q1 2025.